Skip to main navigation
Skip to search
Skip to main content
Sefako Makgatho Health Sciences University Home
Home
Profiles
Departments
Research output
Activities
Search by expertise, name or affiliation
Patent expiry and costs for anti-cancer medicines for clinical use
Brian Godman
*
, Claudia Wild
, Alan Haycox
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Comment/debate
24
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Patent expiry and costs for anti-cancer medicines for clinical use'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Clinical Application
100%
Patent Expiry
100%
Patent Rights
100%
Tyrosine Kinase Inhibitor
100%
Patent Cost
100%
Anticancer Medicines
100%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Protein Tyrosine Kinase Inhibitor
100%